The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.1002/eji.201747450
|View full text |Cite
|
Sign up to set email alerts
|

Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells

Abstract: NK cells lacking CD56 (CD56 ) were first identified in chronic HIV-1 infection. However, CD56 NK cells also exist in healthy individuals, albeit in significantly lower numbers. Here, we provide an extensive proteomic characterisation of human CD56 peripheral blood NK cells of healthy donors and compare them to their CD56 and CD56 counterparts. Unbiased large-scale surface receptor profiling clustered CD56 cells as part of the main NK cell compartment and indicated an overall CD56 -like phenotype. Total proteom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
39
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(48 citation statements)
references
References 61 publications
8
39
1
Order By: Relevance
“…In fact, CD56 neg CD16 pos cells expressed multiple NK cell markers including KIRs, NKG2C, NKp30, CD16a, NKG2D, 2B4, CD57, TRAIL, CRTAM and CRACC. Moreover, our previous study highlighted the phenotypic similarities between these two NK cell subsets (Forconi et al, 2018) which was supported by the Voigt et.al proteomic study (Voigt et al, 2018). Together, these findings confirm that CD56 neg CD16 pos cells are true NK cells.…”
Section: Discussionsupporting
confidence: 81%
See 2 more Smart Citations
“…In fact, CD56 neg CD16 pos cells expressed multiple NK cell markers including KIRs, NKG2C, NKp30, CD16a, NKG2D, 2B4, CD57, TRAIL, CRTAM and CRACC. Moreover, our previous study highlighted the phenotypic similarities between these two NK cell subsets (Forconi et al, 2018) which was supported by the Voigt et.al proteomic study (Voigt et al, 2018). Together, these findings confirm that CD56 neg CD16 pos cells are true NK cells.…”
Section: Discussionsupporting
confidence: 81%
“…Most of the genes differentially expressed when comparing CD56 neg CD16 pos to CD56 dim CD16 pos NK cells that are highlighted in the RNA-sequencing experiment have already been described at the protein expression level in previous studies (Forconi et al, 2018;Voigt et al, 2018). CD56 dim CD16 pos compared to CD56 neg CD16 pos NK cells express less NKp80, IL18Ra, CD161, NKp46, DNAM1 with no differences for CD57, Perforin 1, CD11c, NKG2D, NKG2C and most of the KIRs.…”
Section: Validation Of Gene Expression By Flow Cytometrysupporting
confidence: 52%
See 1 more Smart Citation
“…20 CD56 -CD16 + cells are terminally differentiated cells 21 that have fewer activating and more inhibitory receptors. 22 Thus, CD56 -CD16 + cells are ineffective, or at least less effective, at cytotoxicity and producing cytokines and chemokines including CCR5 ligands (CCL3, CCL4, and CCL5), 9,27 and some propose that their expansion, replacing more functional cells, may facilitate HIV-1 infection of CD4 + T cells. 9 Of note, CD56 -CD16 + NK cells can suppress IFN-c production by CD8 + T cells.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, in healthy donors, both cytokine production and the degranulation capability were increased in the CD56 neg NKp80 + cells (Fig 3B). Our results indicate that, although CD56 neg NK cells have lower effector functions than CD56 dim NK cells (Fig EV6), their functionality might not be completely impaired [26].…”
Section: Resultsmentioning
confidence: 99%